Osteoporosis
📧 Sign up to get email alerts when something new happens for Osteoporosis.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2019-08-16FDA Approved: FOSAMAX PLUS D — Supplemental Application (Organon LLC)
The FDA approved a supplemental application for Fosamax Plus D (alendronate sodium and cholecaliferol) from Organon LLC. This action updates…
-
CLINICAL_TRIALS trial_result · 2019-08-08Clinical Trial Update: Stem Cell Recruitment in Osteoporosis Therapy [NA]
Clinical trial update about stem cell recruitment in osteoporosis therapy; terminated with results posted.
-
CLINICAL_TRIALS trial_result · 2019-08-05Clinical Trial Update: Efficacy and Safety Study of Risedronate, Cholecalciferol Combination Tablet in Patients With Osteoporosis [Phase 4]
Phase 4 trial evaluating the efficacy and safety of a risedronate and cholecalciferol combination tablet in osteoporosis.
-
FDA approval · 2019-07-26FDA Approved: PROLIA — Supplemental Application (Amgen, Inc)
FDA approved a supplemental application for PROLIA (denosumab) filed by Amgen, expanding the regulatory status of the product.
-
CLINICAL_TRIALS trial_result · 2019-07-26Clinical Trial Update: Treating Idiopathic Inflammatory Myopathies Related Reduced Bone Mineral Density With Denosumab or Zoledronic Acid [Phase 3]
Phase 3 clinical trial comparing denosumab vs zoledronic acid for bone mineral density in patients with idiopathic inflammatory myopathies a…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2019-07-24Clinical Trial Update: Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Denosumab (AMG 162) in Japanese Postmenopausal Women [Phase 1]
Phase 1 clinical trial update evaluating denosumab (AMG 162) safety, tolerability, pharmacokinetics, and pharmacodynamics in Japanese postme…
-
CLINICAL_TRIALS trial_result · 2019-07-22Clinical Trial Update: Transdermal Estrogen in Older Premenopausal Women With Anorexia Nervosa [Phase 2]
Phase 2 trial update on transdermal estrogen in older premenopausal women with anorexia nervosa, with osteoporosis as a condition studied; r…
-
CLINICAL_TRIALS trial_result · 2019-07-17Clinical Trial Update: 36-month Special Drug Use Surveillance on Frequency of Bone Fractures With Sodium Risedronate 75 mg Tablets
A completed clinical trial update assessing the frequency of bone fractures with Sodium Risedronate 75 mg tablets in osteoporosis patients, …
-
FDA approval · 2019-07-09FDA Approved: RISEDRONATE SODIUM — Original Application (Sun Pharmaceutical Industires Inc.)
FDA approved Sun Pharmaceutical's risendronate sodium as an original application for a generic product, with indications for osteoporosis-re…
-
CLINICAL_TRIALS trial_result · 2019-07-05Clinical Trial Update: An Efficacy and Safety Trial of Intravenous Zoledronic Acid Twice Yearly in Osteoporotic Children Treated With Glucocorticoids [Phase 3]
Phase 3 trial evaluating intravenous zoledronic acid given twice yearly for osteoporosis in children on glucocorticoids; study completed wit…
-
CLINICAL_TRIALS trial_result · 2019-05-09Clinical Trial Update: Forteo Trial on Idiopathic Osteoporosis in Premenopausal Women [Phase 2]
Phase 2 trial update for Forteo in adults with idiopathic generalized osteoporosis; study completed with results posted.
-
CLINICAL_TRIALS trial_result · 2019-04-30Clinical Trial Update: To Test the Effect of Calcifediol Hy.D Supplementation on Muscle Function and Bone Quality in Younger Postmenopausal Women With Osteopenia [Phase 2]
Phase 2 trial assessing the effect of calcifediol supplementation on muscle function and bone quality in younger postmenopausal women with o…
-
CLINICAL_TRIALS trial_result · 2019-04-26Clinical Trial Update: Bone Histomorphometry in Postmenopausal Men and Women With Osteoarthritis Undergoing Total Hip Replacement [Phase 4]
Phase 4 trial assessing bone histomorphometry in postmenopausal men and women with osteoporosis undergoing total hip replacement; results po…
-
CLINICAL_TRIALS withdrawal · 2019-03-13Clinical Trial Update: Study Of The Efficacy And Security Of Ibandronate For Osteoporosis Treatment In A HIV-Infected Patients Cohort [Phase 4]
A Phase 4 trial evaluating ibandronate for osteoporosis in HIV-infected patients was withdrawn.
-
CLINICAL_TRIALS trial_result · 2019-03-08Clinical Trial Update: Denosumab Administration After Spinal Cord Injury [Phase 4]
A Phase 4 clinical trial update on denosumab administration after spinal cord injury for osteoporosis, with status listed as UNKNOWN.
-
CLINICAL_TRIALS trial_result · 2019-03-04Clinical Trial Update: Transition From Alendronate to Romosozumab (AMG 785) [Phase 1]
Phase 1 trial update describing transition from alendronate to romosozumab (AMG 785) in osteoporosis; results posted.
-
CLINICAL_TRIALS trial_result · 2019-02-26Clinical Trial Update: BREAST CANCER AND EXERCISE [Phase 3]
Phase 3 trial update investigating exercise in breast cancer patients, focusing on osteoporosis prevention, quality of life, physical fitnes…
-
CLINICAL_TRIALS trial_result · 2019-02-25Clinical Trial Update: Study of Romosozumab (AMG 785) Administered to Healthy Participants and Patients With Stage 4 Renal Impairment or Stage 5 Renal Impairment Requiring Hemodialysis [Phase 1]
Phase 1 trial of romosozumab in healthy participants and in patients with severe renal impairment (hemodialysis) completed; results posted.
-
CLINICAL_TRIALS trial_result · 2019-02-22Clinical Trial Update: Prospective Comparative Study to Compare Safety and Effectiveness of Two Vertebral Compression Fracture Reduction Techniques [NA]
This Clinical Trial Update reports the completion of a prospective comparative study evaluating two vertebral compression fracture reduction…
-
CLINICAL_TRIALS trial_result · 2019-02-21Clinical Trial Update: Effect of Adrenocorticotropic Hormone on Vascular Endothelial Growth Factor Release in Children Study [EARLY_Phase 1]
An early-phase 1 trial evaluated whether adrenocorticotropic hormone (ACTH) affects the release of vascular endothelial growth factor (VEGF)…
-
FDA approval · 2019-02-15FDA Approved: RISEDRONATE SODIUM — Original Application (Hangzhou Minsheng Binjiang Pharmaceutical CO., Ltd)
FDA approved the generic drug risedronate sodium under an Original Application, expanding access to this bisphosphonate for osteoporosis- an…
-
CLINICAL_TRIALS trial_result · 2019-02-15Clinical Trial Update: Change in Free 25(OH)D After High Dose in Vitamin D Deficient Postmenopausal Women [NA]
Clinical trial update reporting changes in free 25(OH)D levels after a high-dose vitamin D regimen in vitamin D–deficient postmenopausal wom…
-
CLINICAL_TRIALS trial_result · 2019-02-15Clinical Trial Update: Does Vibration Therapy Induce Higher Than Normal Bone Strains and Strain Rates Than Those Experienced During Habitual Daily Activities [NA]
A completed study evaluating whether vibration therapy induces higher bone strains and strain rates than habitual daily activities in people…
-
EMA withdrawal · 2019-02-14EMA Refused: Eladynos (abaloparatide) — Radius Health Ireland Ltd
The EMA refused the marketing authorization for Eladynos (abaloparatide) for osteoporosis.
-
CLINICAL_TRIALS trial_result · 2019-02-12Clinical Trial Update: Bone Mineral Density Changes Among Clinical Subtypes of Parkinson's Disease
This clinical trial update examines how bone mineral density changes vary among clinical subtypes of Parkinson's disease and their implicati…